IBT Ibex Technologies Inc

IBEX Technologies Inc. (TSX VENTURE: IBT), reminds shareholders that the Annual Meeting of Shareholders will be held at 8:30 AM on March 16, 2010 at the Hotel Ruby Foos, 7655 Decarie Boulevard, Montreal.

Shareholders are invited to attend the meeting, or to submit their proxies by 5:00 PM on March 12, 2010.

ABOUT IBEX

IBEX manufactures and markets a series of proprietary enzymes (heparinases and chondroitinases) for use in pharmaceutical research by our customers, as well Heparinase I, which is used in many leading hemostasis monitoring devices.

IBEX also manufactures and markets a series of arthritis assays which are widely used in pharmaceutical research by our customers. These assays are based on the discovery and increasing role of a number of specific molecular biomarkers associated with collagen synthesis and degradation.

For more information, please visit the Company's web site at www.ibex.ca.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release

Contacts: IBEX Technologies Inc. Paul Baehr President & CEO 514-344-4004 x 143 www.ibex.ca